BIOTIME ORD(BTX)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BTX BIOTIME ORD

已收盘 10-14 16:00:00 EDT

0.2051

+0.0000

0.00%

最高0.2051	最低0.2051	成交量0.00
今开0.2051	昨收0.2051	日振幅0.00%
总市值60.33万	流通市值34.92万	总股本294.13万
成交额49.12万	换手率0.00%	流通股本170.26万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BTX","market":"US","secType":"STK","nameCN":"BIOTIME ORD","latestPrice":0.2051,"timestamp":1665777600000,"preClose":0.2051,"halted":8,"volume":0,"delay":0,"floatShares":1702625,"shares":2941286,"eps":-39.75382,"marketStatus":"已收盘","marketStatusCode":5,"change":0,"latestTime":"10-14 16:00:00 EDT","open":0.2051,"high":0.2051,"low":0.2051,"amount":491177.897244,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-39.75382,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732006800000},"symbolChange":{"newSymbol":"ERNA","executeDate":"2022-10-17"},"adr":0,"listingDate":465451200000,"adjPreClose":0.2051,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/BTX","defaultTab":"news","newsList":[{"id":"2263791283","title":"Brooklyn Immuno Therapeutics Inc盘中异动 早盘急速上涨5.29%报0.434美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2263791283","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2263791283?lang=zh_cn&edition=full","pubTime":"2022-08-31 21:33","pubTimestamp":1661952798,"startTime":"0","endTime":"0","summary":"北京时间2022年08月31日21时33分，Brooklyn Immuno Therapeutics Inc股票出现异动，股价急速上涨5.29%。Brooklyn Immuno Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.85%。Brooklyn Immuno Therapeutics Inc公司简介：NTN Buzztime, Inc. engages in the provision of venue social gaming and marketing entertainment services. It offers entertainment and dining technology to bars and restaurants in North America. The company was founded in 1984 and is headquartered in Carlsbad, CA.消息层面，截至21时33分，Brooklyn Immuno Therapeutics Inc股票正面舆情新闻比例50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022083121331982921c10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022083121331982921c10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BTX","BK4139"],"gpt_icon":0},{"id":"2263927143","title":"Brooklyn ImmunoTherapeutics, Inc.(BTX.US)：2022年Q2财报实现每股收益为-0.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2263927143","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2263927143?lang=zh_cn&edition=full","pubTime":"2022-08-29 09:36","pubTimestamp":1661737006,"startTime":"0","endTime":"0","summary":"Brooklyn ImmunoTherapeutics公司简介：布鲁克林免疫疗法公司是一家临床阶段的生物制药公司，致力于为癌症、血液疾病和单基因疾病创造变革性再生医学疗法。它提供IRX-2，一种人类细胞衍生细胞因子疗法，研究IRX-2在2B期头颈癌患者中的安全性和有效性。该公司总部设在加利福尼亚州圣地亚哥。以上内容由证券之星根据公开信息整理，与本站立场无关。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220829093649821db596&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220829093649821db596&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BTX"],"gpt_icon":0},{"id":"2262979932","title":"Brooklyn Immuno Therapeutics Inc盘中异动 早盘急速下挫5.97%报0.405美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2262979932","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2262979932?lang=zh_cn&edition=full","pubTime":"2022-08-26 23:06","pubTimestamp":1661526389,"startTime":"0","endTime":"0","summary":"北京时间2022年08月26日23时06分，Brooklyn Immuno Therapeutics Inc股票出现波动，股价大幅跳水5.97%。截至发稿，该股报0.405美元/股，成交量23.6583万股，换手率0.40%，振幅10.82%。Brooklyn Immuno Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.98%。Brooklyn Immuno Therapeutics Inc公司简介：NTN Buzztime, Inc. engages in the provision of venue social gaming and marketing entertainment services. It offers entertainment and dining technology to bars and restaurants in North America. The company was founded in 1984 and is headquartered in Carlsbad, CA.消息层面，截至23时06分，Brooklyn Immuno Therapeutics Inc股票正面舆情新闻比例50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022082623063080584bb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022082623063080584bb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BTX"],"gpt_icon":0},{"id":"2261656906","title":"Brooklyn Immuno Therapeutics Inc盘中异动 急速上涨6.52%报0.495美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2261656906","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2261656906?lang=zh_cn&edition=full","pubTime":"2022-08-23 21:32","pubTimestamp":1661261524,"startTime":"0","endTime":"0","summary":"北京时间2022年08月23日21时32分，Brooklyn Immuno Therapeutics Inc股票出现波动，股价快速上涨6.52%。Brooklyn Immuno Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Windtree Therapeutics Inc、天境生物、Avenue Therapeutics Inc涨幅较大，Windtree Therapeutics Inc、Bright Minds Biosciences Inc、Scisparc Ltd较为活跃，换手率分别为42.59%、9.02%、5.73%，振幅较大的相关个股有Windtree Therapeutics Inc、天境生物、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为17.37%、11.30%、9.19%。Brooklyn Immuno Therapeutics Inc公司简介：Brooklyn ImmunoTherapeutics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220823213207821b2030&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220823213207821b2030&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BTX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lineagecell.com","stockEarnings":[{"period":"1week","weight":-0.95},{"period":"1month","weight":-0.95},{"period":"3month","weight":-0.95},{"period":"6month","weight":-0.95},{"period":"1year","weight":-0.95},{"period":"ytd","weight":-0.95}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lineage Cell Therapeutics, Inc.于1990年在加利福尼亚州成立。该公司是一家生物技术公司，专注于再生医学这一新兴领域。其核心技术集中于干细胞，这种细胞具有多功能属性，即能够成为人体内的所有细胞类型。从这些“多能”干细胞出发，该公司及其子公司集中于不同的医疗专业开发产品，包括神经科学、肿瘤学、骨科、血液和血管疾病。其商业战略主要侧重于包括目前研究产品线在内的短期商业机会，如PureStem细胞系（原被称为ACTCellerate细胞系）和与其相关的ESpan培养基、HyStem水凝胶、人胚胎干细胞系以及Hextend使用费。其长期战略重点是提供与年龄有关的退化性疾病的再生疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.533333,"avgChangeRate":0.123929},{"month":2,"riseRate":0.433333,"avgChangeRate":-0.004011},{"month":3,"riseRate":0.6,"avgChangeRate":0.031304},{"month":4,"riseRate":0.366667,"avgChangeRate":0.39675},{"month":5,"riseRate":0.366667,"avgChangeRate":-0.040005},{"month":6,"riseRate":0.533333,"avgChangeRate":0.031842},{"month":7,"riseRate":0.258065,"avgChangeRate":-0.041592},{"month":8,"riseRate":0.419355,"avgChangeRate":-0.021118},{"month":9,"riseRate":0.354839,"avgChangeRate":-0.007429},{"month":10,"riseRate":0.322581,"avgChangeRate":-0.077875},{"month":11,"riseRate":0.533333,"avgChangeRate":0.103628},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.076133}],"exchange":"NYSE","name":"BIOTIME ORD","nameEN":"BIOTIME ORD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BIOTIME ORD(BTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BIOTIME ORD(BTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BIOTIME ORD,BTX,BIOTIME ORD股票,BIOTIME ORD股票老虎,BIOTIME ORD股票老虎国际,BIOTIME ORD行情,BIOTIME ORD股票行情,BIOTIME ORD股价,BIOTIME ORD股市,BIOTIME ORD股票价格,BIOTIME ORD股票交易,BIOTIME ORD股票购买,BIOTIME ORD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BIOTIME ORD(BTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BIOTIME ORD(BTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况